8,517 articles
Joel D. Meyers
Joel D. Meyers was an American physician and infectious disease epidemiologist at Fred Hutchinson Cancer Research Center who identified cytomegalovirus risk factors in bone marrow transplant patients.
Joel E. Richter
Joel E. Richter is an American gastroenterologist specializing in esophageal diseases, who led gastroenterology at USF after chairing it at the Cleveland Clinic and medicine at Temple University.
Joel Elmquist
Joel Elmquist is an American neuroscientist at UT Southwestern Medical Center who studies how the hypothalamus controls energy balance and glucose homeostasis, known for mouse-genetics work on leptin and melanocortin pathways.
Joel F. Habener
Joel F. Habener (1937–2025) was an American endocrinologist at Massachusetts General Hospital and Harvard Medical School whose discovery of GLP-1 led to drugs for diabetes and obesity.
Joel G. Breman
Joel G. Breman, also known as Joel Breman, was an American physician-scientist who helped certify smallpox eradication, investigated the first Ebola outbreak in 1976, and led malaria research at the CDC.
Joel Kaufman
Joel Kaufman, also known as Joel D. Kaufman, is an American physician-epidemiologist at the University of Washington who established that long-term air pollution exposure accelerates atherosclerosis and cardiovascular disease.
Joel L. Moake
Joel L. Moake is a physician-scientist in hematology at Rice University and Baylor College of Medicine who discovered how von Willebrand factor drives platelet clumping in TTP.
Joel M. Palefsky
Joel M. Palefsky is an infectious diseases physician and professor of medicine at UCSF known for research on HPV and anal cancer prevention in people with HIV.
Joel Moss
Joel Moss is a physician-scientist at the National Heart, Lung, and Blood Institute whose research spans ADP-ribosylation biochemistry and lymphangioleiomyomatosis, a progressive cystic lung disease affecting primarily women.
Joel S. Finkelstein
Joel S. Finkelstein (1954–2026) was an American endocrinologist at Massachusetts General Hospital and Harvard Medical School who showed that estrogen, not only testosterone, drives many symptoms of low testosterone in men.
Joel S. Weissman
Joel S. Weissman is a health services researcher at Brigham and Women's Hospital and Harvard Medical School, known for research on quality, patient safety, and care of the poor.
Joel Schwartz
Joel Schwartz, also known as Joel D. Schwartz, is an environmental epidemiologist at Harvard whose work on air pollution and lead drove tighter U.S. standards.
Joffre Baker
Joffre Baker is a biochemist and cancer researcher known for discovering protease-nexin, a cell-surface protease regulator, and for the Oncotype DX 21-gene breast cancer test developed at Genomic Health.
Johan Askling
Johan Askling is a Swedish physician and epidemiologist who is professor of rheumatology at Karolinska Institutet, studying cancer risks in inflammatory disease and drug safety.
Johan Auwerx
Johan Auwerx, born 1958, is a Belgian biologist and professor at EPFL in Switzerland, holding the Nestlé Chair in Energy Metabolism and studying mitochondria, NAD+, sirtuins, and longevity.
Johan Elf
Johan Elf, born 1975, is a Swedish physical biologist and professor at Uppsala University who tracks single molecules in living cells and founded Astrego Diagnostics, whose PA-100 system tests antibiotic susceptibility in 45 minutes.
Johan G. Eriksson
Johan G. Eriksson, also known as Johan Eriksson, is a Finnish physician and epidemiologist, born in 1958, who studies how early growth shapes later heart disease and diabetes risk.
Johan Maertens
Johan Maertens is a Belgian infectious-diseases physician-scientist at KU Leuven and UZ Leuven who studies invasive fungal disease and febrile neutropenia in hematologic cancer patients.
Johan P. Mackenbach
Johan P. Mackenbach is a Dutch physician-epidemiologist and Professor Emeritus of Public Health at Erasmus MC, Rotterdam, known for measuring and explaining socioeconomic inequalities in health across Europe.
Johann Bauersachs
Johann Bauersachs is a German cardiologist and director of cardiology at Hannover Medical School since 2010, known for microRNAs in heart failure and the DIGIT-HF trial.
Johann Georg Mönckeberg
Johann Georg Mönckeberg (1877–1925) was a German pathologist, born in Hamburg, who first described Mönckeberg medial calcific sclerosis, a non-obstructive calcification of muscular arteries, in 1903 and held pathology chairs at Düsseldorf, Strassburg, Tübingen, and Bonn.
Johann Hoffmann (neurologist)
Johann Hoffmann (1857–1919) was a German neurologist who spent his career at Heidelberg and is known for Werdnig–Hoffmann disease, Hoffmann's syndrome, and the finger-flexion Hoffmann sign.
Johann S. de Bono
Johann S. de Bono, also known as Johann de Bono, is a British medical oncologist and Regius Professor of Cancer Research who led pivotal trials of abiraterone, enzalutamide, and olaparib.
Johanna Joyce
Johanna A. Joyce is a cancer biologist and Full Professor of Oncology at the University of Lausanne, known for reprogramming tumor-associated macrophages to slow glioblastoma.
Johanna M. Seddon
Johanna M. Seddon is an American ophthalmologist and genetic epidemiologist who established macular degeneration as a disease of both lifestyle and inherited risk, directing the Macular Degeneration Center of Excellence at UMass Chan Medical School.
Johannes D. Veldhuis
Johannes D. Veldhuis, also known as J. D. Veldhuis, is an endocrinologist at Mayo Clinic in Rochester, Minnesota, known for deconvolution methods that measure pulsatile hormone secretion and its decline with aging.
Johannes F.E. Mann
Johannes F.E. Mann, also known as Johannes Mann, is a German nephrologist, Professor of Medicine at Erlangen-Nürnberg since 1989, known for kidney and cardiovascular protection trials in diabetes.
Johannes Herrmann
Johannes M. Herrmann is a German cell biologist, professor at RPTU Kaiserslautern-Landau since 2006, known for the mitochondrial disulfide relay and ER-SURF pathways; he joined the Leopoldina in 2020.
Johannes Zuber
Johannes Zuber, born 1974 in Dresden, is an Austrian-based molecular biologist and Senior Group Leader at the Research Institute of Molecular Pathology in Vienna, studying cancer dependencies through functional genomics.
John A. Baron
John A. Baron is an American physician and clinical epidemiologist known for randomized chemoprevention trials in colorectal cancer prevention, including the Calcium Polyp Prevention Study, and professor emeritus at Dartmouth.